In treatment of depression with adjunctive aripiprazole, early improvement (week 2) was a significant predictor of remission, and lack of improvement was associated with nonremission.
Jessie S. Chambers, PhD
Advertisement
Articles by Jessie S. Chambers, PhD
Advertisement
Latest Updated Articles
- Adjunctive Aripiprazole for Depression: Predictive Value of Early Assessment
Published: December 22nd 2011 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
After Narrow Miss in Phase 3 Study, IO Biotech Ponders Next Steps for Immune-Modulatory, Off-the-Shelf Cancer Vaccine
2
3 New Study Findings to Look Out for at Menopause Society 2025
3
Ongoing COVID-19 Circulation Linked to Increases in Health-Related Work Absences, Workforce Exits
4
Guidelines for Bronchiectasis Highlight Multiple Treatment Methods
5
